[PR Newswire] - WASHINGTON, July 31, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment